'''SDB-006''' is a drug that acts as a potent [[agonist]] for the [[cannabinoid receptor]]s, with an EC<sub>50</sub> of 19 nM for human CB<sub>2</sub> receptors, and 134 nM for human CB<sub>1</sub> receptors.<ref>{{Cite journal | doi = 10.1021/acschemneuro.5b00107| title = Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135| journal = ACS Chemical Neuroscience| pages = 150508124201002| year = 2015| last1 = Banister | first1 = S. D. | last2 = Stuart | first2 = J. | last3 = Kevin | first3 = R. C. | last4 = Edington | first4 = A. | last5 = Longworth | first5 = M. | last6 = Wilkinson | first6 = S. M. | last7 = Beinat | first7 = C. | last8 = Buchanan | first8 = A. S. | last9 = Hibbs | first9 = D. E. | last10 = Glass | first10 = M. | last11 = Connor | first11 = M. | last12 = McGregor | first12 = I. S. | last13 = Kassiou | first13 = M. | volume=6 | pmid=25921407}}</ref> It was discovered during research into the related compound [[SDB-001]] which had been sold illicitly as "2NE1".<ref>{{Cite journal | last1 = Banister | first1 = S. D. | last2 = Wilkinson | first2 = S. M. | last3 = Longworth | first3 = M. | last4 = Stuart | first4 = J. | last5 = Apetz | first5 = N. | last6 = English | first6 = K. | last7 = Brooker | first7 = L. | last8 = Goebel | first8 = C. | last9 = Hibbs | first9 = D. E. | last10 = Glass | first10 = M. | last11 = Connor | first11 = M. | last12 = McGregor | first12 = I. S. | last13 = Kassiou | first13 = M. | title = The synthesis and pharmacological evaluation of adamantane-derived indoles: Novel cannabimimetic drugs of abuse | doi = 10.1021/cn400035r | journal = ACS Chemical Neuroscience | volume = 4 | issue = 7 | pages = 130403084729007 | year = 2013 | pmid =  23551277| pmc = 3715837}}</ref>
